Literature DB >> 21194755

Effect of 5-HT1A-receptor functional polymorphism on Theory of Mind performances in schizophrenia.

Marta Bosia1, Simona Anselmetti, Margherita Bechi, Cristina Lorenzi, Adele Pirovano, Federica Cocchi, Mariachiara Buonocore, Placido Bramanti, Enrico Smeraldi, Roberto Cavallaro.   

Abstract

Theory of Mind (ToM) abilities are known to be impaired in schizophrenia and data from functional brain imaging studies showed that ToM deficit is correlated to prefrontal cortex (PFC) dysfunction. Moreover, several lines of evidence suggest a critical role for dopaminergic-serotoninergic interactions at the PFC level. In this view, we aimed to analyse the specific effect of the -1019C/G functional polymorphism of the serotonin 1A receptor (5-HT1A-R), involved in both serotonin and dopamine transmission regulation. A total of 118 clinically stabilised schizophrenia patients was assessed with a neuropsychological battery, including evaluation of IQ, verbal memory, attention and executive function and a ToM task; they also underwent 5-HT1A-R genotyping. We observed a significant effect of the 5-HT1A-R genotype on ToM performances, with the CC genotype performing significantly better. The finding suggests an effect of the 5-HT1A-R polymorphism on ToM cognitive performance in schizophrenia patients, probably through complex interactions between dopaminergic and serotoninergic systems, involved in mentalising.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21194755     DOI: 10.1016/j.psychres.2010.11.014

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

1.  Theory of mind network activity is altered in subjects with familial liability for schizophrenia.

Authors:  Sebastian Mohnke; Susanne Erk; Knut Schnell; Nina Romanczuk-Seiferth; Phöbe Schmierer; Lydia Romund; Maria Garbusow; Carolin Wackerhagen; Stephan Ripke; Oliver Grimm; Leila Haller; Stephanie H Witt; Franziska Degenhardt; Heike Tost; Andreas Heinz; Andreas Meyer-Lindenberg; Henrik Walter
Journal:  Soc Cogn Affect Neurosci       Date:  2015-09-04       Impact factor: 3.436

2.  Association of Anxiety-Related Polymorphisms with Sports Performance in Chilean Long Distance Triathletes: A Pilot Study.

Authors:  Jorge A Sanhueza; Tomás Zambrano; Carlos Bahamondes-Avila; Luis A Salazar
Journal:  J Sports Sci Med       Date:  2016-12-01       Impact factor: 2.988

3.  5-HT1A parital agonism and 5-HT7 antagonism restore episodic memory in subchronic phencyclidine-treated mice: role of brain glutamate, dopamine, acetylcholine and GABA.

Authors:  Mei Huang; Sunoh Kwon; Lakshmi Rajagopal; Wenqi He; Herbert Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2018-07-31       Impact factor: 4.530

4.  COMT and 5-HT1A-receptor genotypes potentially affect executive functions improvement after cognitive remediation in schizophrenia.

Authors:  Marta Bosia; Margherita Bechi; Adele Pirovano; Mariachiara Buonocore; Cristina Lorenzi; Federica Cocchi; Placido Bramanti; Enrico Smeraldi; Roberto Cavallaro
Journal:  Health Psychol Behav Med       Date:  2014-04-28

5.  Decoding emotion of the other differs among schizophrenia patients and schizoaffective patients: A pilot study.

Authors:  Hagar Tadmor; Maya Levin; Tzameret Dadon; Meital E Meiman; Alaa Ajameeh; Hosam Mazzawi; Amihai Rigbi; Ilana Kremer; Idit Golani; Alon Shamir
Journal:  Schizophr Res Cogn       Date:  2016-06-22

Review 6.  Towards in vivo imaging of functionally active 5-HT1A receptors in schizophrenia: concepts and challenges.

Authors:  Oriane Razakarivony; Adrian Newman-Tancredi; Luc Zimmer
Journal:  Transl Psychiatry       Date:  2021-01-07       Impact factor: 6.222

7.  Association Between Lack of Insight and Prefrontal Serotonin Transporter Availability in Antipsychotic-Free Patients with Schizophrenia: A High-Resolution PET Study with [11C]DASB.

Authors:  Jeong-Hee Kim; Young-Don Son; Hang-Keun Kim; Jong-Hoon Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2021-10-21       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.